BioStock: Mentice launches Ankyras in Brazil

Mentice has officially launched its treatment planning solution, Ankyras, in Brazil after receiving regulatory clearance from ANVISA, Brazil’s National Health Surveillance Agency. According to the company, this marks a significant advancement of intracranial aneurysm care in Latin America, enabling physicians to leverage virtual rehearsal and patient-specific simulation to improve clinical outcomes.

Read the full article at biostock.se:

https://www.biostock.se/2025/05/mentice-launches-ankyras-in-brazil/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se